Scott Dylla

Scott Dylla is the current advisor at Multiply Labs. Scott has also been a part of Chimera Bioengineering, AbbVie Stemcentrx, LLC, and Stemcentrx, Inc. Scott was the co-founder and Chief Scientific Officer at Stemcentrx, Inc. and has also worked as a Sr. Scientist at OncoMed Pharmaceuticals and a Postdoctoral Scholar at Stanford University School of Medicine.

Scott Dylla has a Ph.D. in Cancer Biology & Immunology from the University of Minnesota, an M.S. in Molecular & Cellular Pathobiology from the University of Alabama at Birmingham, and a B.S. in Biochemistry & Molecular Biology from the University of Minnesota Duluth.